Literature DB >> 22129101

Topical application of 0.005% latanoprost increases episcleral venous pressure in normal dogs.

Susan Tsai1, Paul E Miller, Craig Struble, Susan Howard, Alexandra Almazan, James A Burke, Patrick M Hughes, Huajiang Li, Paul Conforti, Susan S Lee, Michael R Robinson.   

Abstract

INTRODUCTION: Episcleral venous pressure (EVP) has an important role in intraocular pressure (IOP) homeostasis and accounts for more than 70% of the IOP in the normal dog. A frequently used species in glaucoma research is the normotensive dog especially when evaluating the efficacy of prostaglandin analogues and prostamides; however, aqueous humor dynamic studies in normal dogs are lacking, and the effect of 0.005% latanoprost on canine EVP is not known. We sought to determine the effects to the EVP of topically applied 0.005% latanoprost in the normotensive beagle dog.
METHODS: Female beagle dogs (n = 14) were used and each had a normal ophthalmic examination on study entry. EVP was determined using a standard episcleral venomanometer. Animals were dosed in one eye with 0.005% latanoprost, and the effects on EVP were compared with the averaged baseline EVP's determined in the predosing phase and the fellow nondosed eye. The Mixed Model Repeated Measures method was used to analyze the EVP data.
RESULTS: During the dosing phase of the study with topical 0.005% latanoprost, the mean EVPs of dosed eyes were significantly higher than that of nondosed eyes (P < 0.0001).
CONCLUSIONS: The increase in EVP in the dog with exposure to topical 0.005% latanoprost has not been observed in other species that have been studied, such as in the mouse and in humans, where the drug had no significant effect on the EVP. This response may be unique to dogs and suggests that dogs may not fully mimic human aqueous humor dynamics with topical 0.005% latanoprost. Although frequently performed in human studies, EVP should not be regarded to be a constant value in aqueous humor dynamic studies in the normal beagle dog.
© 2012 American College of Veterinary Ophthalmologists.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22129101     DOI: 10.1111/j.1463-5224.2011.00970.x

Source DB:  PubMed          Journal:  Vet Ophthalmol        ISSN: 1463-5216            Impact factor:   1.644


  8 in total

1.  Effect of topical latanoprost 0.005% on intraocular pressure and pupil diameter in normal and glaucomatous cats.

Authors:  Jessica E McDonald; Julie A Kiland; Paul L Kaufman; Ellison Bentley; N Matthew Ellinwood; Gillian J McLellan
Journal:  Vet Ophthalmol       Date:  2015-07-16       Impact factor: 1.644

2.  In vivo evaluation of the cornea and conjunctiva of the normal laboratory beagle using time- and Fourier-domain optical coherence tomography and ultrasound pachymetry.

Authors:  Ann R Strom; Dennis E Cortés; Carol A Rasmussen; Sara M Thomasy; Kim McIntyre; Shwu-Fei Lee; Philip H Kass; Mark J Mannis; Christopher J Murphy
Journal:  Vet Ophthalmol       Date:  2015-02-10       Impact factor: 1.644

3.  Safety and efficacy of topically administered netarsudil-latanoprost fixed dose combination (FDC; Rocklatan™) in normal and glaucomatous dogs with ADAMTS10-open-angle glaucoma (ADAMTS10-OAG).

Authors:  Kelly A Leary; Juan P Steibel; Christine D Harman; Amanda L Anderson; András M Komáromy
Journal:  Vet Ophthalmol       Date:  2021-06-04       Impact factor: 1.644

4.  Intraocular Pressure Effects and Mechanism of Action of Topical Versus Sustained-Release Bimatoprost.

Authors:  Susan S Lee; Alexandra Almazan; Sherri Decker; Yan Zhong; Alazar N Ghebremeskel; Patrick Hughes; Michael R Robinson; James A Burke; Robert N Weinreb
Journal:  Transl Vis Sci Technol       Date:  2019-01-30       Impact factor: 3.283

Review 5.  The future of canine glaucoma therapy.

Authors:  András M Komáromy; Dineli Bras; Douglas W Esson; Ronald L Fellman; Sinisa D Grozdanic; Larry Kagemann; Paul E Miller; Sayoko E Moroi; Caryn E Plummer; John S Sapienza; Eric S Storey; Leandro B Teixeira; Carol B Toris; Terah R Webb
Journal:  Vet Ophthalmol       Date:  2019-05-20       Impact factor: 1.644

6.  Episcleral Venous Pressure and the Ocular Hypotensive Effects of Topical and Intracameral Prostaglandin Analogs.

Authors:  Susan S Lee; Michael R Robinson; Robert N Weinreb
Journal:  J Glaucoma       Date:  2019-09       Impact factor: 2.503

Review 7.  Vascular Aspects in Glaucoma: From Pathogenesis to Therapeutic Approaches.

Authors:  Anna-Sophie Mursch-Edlmayr; Matthias Bolz; Clemens Strohmaier
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

Review 8.  Matrix Metalloproteinases and Glaucoma Treatment.

Authors:  Robert N Weinreb; Michael R Robinson; Mohammed Dibas; W Daniel Stamer
Journal:  J Ocul Pharmacol Ther       Date:  2020-04-01       Impact factor: 2.671

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.